UK experience using the ESSURE™ micro-insert for hysteroscopic sterilisation

Rogerson, Lynne; Hudson, Heather; Duffy, Sean

doi:10.1016/s1471-7697(02)00061-8

Cited by 11 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Success rates have generally improved over time from 85% 9 to 98% 4 particularly after a new delivery catheter design replaced a braided mesh system with the nitinol coil device. The UK pilot study by Rogerson et al 10 achieved successful bilateral placement in 12/14 cases, with successful placement for the remaining two patients who initially had unilateral placement. UK multicentre experience 6 with 59 patients resulted in a surprisingly low bilateral placement rate of 81%.…”

Section: Methodsmentioning

confidence: 99%

Hysteroscopic sterilisation with Essure(R): a promising new alternative to tubal ligation?

Sagili

Divers²

2008

Journal of Family Planning and Reproductive Health Care

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Hysteroscopic sterilisation with Essure(R): a promising new alternative to tubal ligation?

Sagili

Divers²

2008

Journal of Family Planning and Reproductive Health Care

View full text Add to dashboard Cite

“…The device then induces an inflammatory process, which leads to occlusion of the fallopian tubes. Placement was performed according to the manufacturer's instructions (6). Optimal placement was considered to be three to eight coils remaining visible in the uterine cavity.…”

Section: Methodsmentioning

confidence: 99%

Satisfaction and tolerance with office hysteroscopic tubal sterilization

Arjona

Miño

Cordón

et al. 2008

Fertility and Sterility

104

View full text Add to dashboard Cite

“…Continuous flow hysteroscopy was employed using a 5.5‐mm hysteroscope (Olympus, KeyMed, UK). ESSURE micro‐insert hysteroscopic sterilisation involves the bilateral placement of a coiled micro‐insert into the proximal section of the fallopian tube, under hysteroscopic visualisation 5 . The device then induces an inflammatory process, which leads to occlusion of the fallopian tubes.…”

Section: Methodsmentioning

confidence: 99%

“…A new method of hysteroscopic sterilisation has been developed and investigated through phase 2 and phase 3 trials. The ESSURE micro‐insert allows the placement of microcoils into the fallopian tubes hysteroscopically and can be successfully carried out in an outpatient setting 5 . Hysteroscopic placement of these micro‐inserts does not normally require GA or an operating theatre facility.…”

Section: Introductionmentioning

confidence: 99%

Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation

Duffy

Marsh

Rogerson

et al. 2005

BJOG

Self Cite

130

View full text Add to dashboard Cite

Objective To compare patient satisfaction, discomfort, procedure time, success rate and adverse events of hysteroscopic (ESSURE, Conceptus Inc, San Carlos, USA) versus laparoscopic sterilisation. Design Cohort controlled comparative study.Setting The day surgery and outpatient unit of three large UK hospitals.Population Eighty-nine women requesting sterilisation were enrolled into the study.Methods A 2:1 ratio of ESSURE placement to laparoscopic sterilisation was undertaken. Laparoscopic sterilisation was carried out under general anaesthesia in the day surgery unit whereas all ESSURE procedures were carried out in a dedicated outpatient facility. All patients completed a self-assessment diary on days 7 and 90 post-operatively. Patient satisfaction, tolerance and discomfort were measured using an ordinal Likert style scale. Data were analysed using the m 2 test for statistical significance. Main outcome measures The primary outcome measure is patient satisfaction with ESSURE versus laparoscopic sterilisation. This included satisfaction with the decision to proceed with the relevant sterilisation method, recovery from the procedure and overall satisfaction following either ESSURE or laparoscopic sterilisation. Secondary outcome measures include successful completion of procedure, procedure time, tolerance, patient discomfort and post-operative adverse events. Results All women who underwent laparoscopic sterilisation had the procedure successfully completed whereas the overall bilateral device placement rate for ESSURE was 81%. Patient satisfaction with their decision to undergo either ESSURE or laparoscopic sterilisation was high with 94% of the ESSURE group being 'very' or 'somewhat' satisfied at 90 days post-procedure versus 80% in the laparoscopic sterilisation group. At 90 days post-procedure 100% of women in the ESSURE group were 'very satisfied' with their speed of recovery versus 80% in the laparoscopic sterilisation group. The procedure time (defined from the time of insertion of the hysteroscope or laparoscope to its removal) took significantly longer for ESSURE than laparoscopic sterilisation (mean ¼ 13.2 vs 9.7 minutes, P ¼ 0.045). However, the time required for insertion of a Verres needle and insufflation of the abdominal cavity is a necessary part of the laparoscopic sterilisation and had it been included would bring the procedures times more in line with each other. The mean time spent in hospital was significantly shorter for the ESSURE group than the laparoscopic group (188.7 vs 396.1 minutes, P < 0.005). Eighty-two percent of women in the ESSURE group described their tolerance of the procedure between 'good and excellent' compared with only 41% of the laparoscopic sterilisation group (P ¼ 0.0002). Only 31% of the ESSURE group reported moderate or severe pain following the procedure compared with 63% of the laparoscopic sterilisation group (P ¼ 0.08). Only 11% of patients had problems immediately post-operatively in the ESSURE group compared with 27% in the laparoscopy group. Finally, in the mor...

show abstract

UK experience using the ESSURE™ micro-insert for hysteroscopic sterilisation

Cited by 11 publications

References 5 publications

Hysteroscopic sterilisation with Essure(R): a promising new alternative to tubal ligation?

Hysteroscopic sterilisation with Essure(R): a promising new alternative to tubal ligation?

Satisfaction and tolerance with office hysteroscopic tubal sterilization

Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation

Contact Info

Product

Resources

About